China Resources Double-Crane Pharmaceutical Co (SHSE:600062) YoY Rev. per Sh. Growth : 2.18% (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. China Resources Double-Crane Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 2.18%.

China Resources Double-Crane Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥2.76.

China Resources Double-Crane Pharmaceutical Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co YoY Rev. per Sh. Growth Chart

China Resources Double-Crane Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

14.05

-9.35

7.15

6.42

7.26

China Resources Double-Crane Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															11.89	0.81	5.31	12.75	2.18

China Resources Double-Crane Pharmaceutical Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

China Resources Double-Crane Pharmaceutical Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(9.97	-	9.295)	/	\| 9.295 \|
=	7.26 %

China Resources Double-Crane Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=	(Revenue per Share (Q: Mar. 2024 )	-	Revenue per Share (Q: Mar. 2023 ))	/	\| Revenue per Share (Q: Mar. 2023 )) \|
=	(2.76	-	2.701)	/	\| 2.701 \|
=	2.18 %

China Resources Double-Crane Pharmaceutical Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » YoY Rev. per Sh. Growth

Traded in Other Exchanges

N/A

Address

No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102

Website

http://www.dcpc.com

China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines